Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M β-lactamases

Clinical Microbiology and Infection

Volumn 12, Issue 12, 2006, Pages 1199-1206

  Lavigne, J P ^a,b   Blanc Potard, A B ^c   Bourg, G ^c   Moreau, J ^d   Chanal, C ^e   Bouziges, N ^a,b   O'Callaghan, D ^c   Sotto, Albert ^a  

^a Laboratoire Universitaire d'Antibiologie   (France)

^b DEPARTMENT OF NEUROLOGY   (France)

^c INSERM   (France)

^d UNIVERSITÉ DE BOURGOGNE   (France)

^e ONERA   (France)

Author keywords

Caenorhabditis elegans; CTX M; Escherichia coli; Pathogenicity; Urinary tract infection; Virulence factors

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NETILMICIN; NORFLOXACIN; OFLOXACIN; PEFLOXACIN; PROTEIN IUTA; PROTEIN TRAT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME SYNTHESIS; ESCHERICHIA COLI; FEMALE; FRANCE; GENOTYPE; HUMAN; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; URINARY TRACT INFECTION;

CAENORHABDITIS ELEGANS; ESCHERICHIA COLI; NEMATODA;

EID: 33751102371     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01536.x     Document Type: Article

References (46)

1. Bonnet R. Growing group of extended-spectrum beta-lactamases: The CTX-M enzymes. Antimicrob Agents Chemother 2004; 48: 1-14.
2. Gupta K. Addressing antibiotic resistance. Dis Mon 2003; 49: 99-110.
3. Ronald A. The etiology of urinary tract infection: Traditional and emerging pathogens. Dis Mon 2003; 49: 71-82.
4. Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H. Pathogenicity islands of virulent bacteria: Structure, function and impact on microbial evolution. Mol Microbiol 1997; 23: 1089-1097.
5. Johnson JR. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4: 80-128.
6. Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis 2000; 181: 261-272.
7. Oelschlaeger TA, Dobrindt U, Hacker J. Virulence factors of uropathogens. Curr Opin Urol 2002; 12: 33-38.
8. Branger C, Zamfir O, Geoffroy S et al. Genetic background of Escherichia coli and extended-spectrum β-lactamase type. Emerg Infect Dis 2005; 11: 54-61.
9. Drews SJ, Poutanen SM, Mazzulli T et al. Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates. J Clin Microbiol 2005; 43: 4218-4220.
10. Horcajada JP, Soto S, Gajewski A et.al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J Clin Microbiol 2005; 43: 2962-2964.
11. Johnson JR, van der Schee C, Kuskowski MA, Goessens W, van Belkum A. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J Infect Dis 2002; 186: 1852-1856.
12. Johnson JR, Kuskowski MA, Owens K, Gajewski A, Winokur PL. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J Infect Dis 2003; 188: 759-768.
13. Johnson JR, Kuskowski MA, O'Bryan TT, Colodner R, Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob Agents Chemother 2005; 49: 26-31.
14. Vila J, Simon K, Ruiz J et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent? J Infect Dis 2002; 186: 1039-1042.
15. Leflon-Guibout V, Jurand C, Bonacorsi S et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob Agents Chemother 2004; 48: 3736-3742.
16. Pitout JD, Laupland KB, Church DL, Menard ML, Johnson JR. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob Agents Chemother 2005; 49: 4667-4670.
17. Picard B, Garcia JS, Gouriou S et al. The link between phylogeny and virulence in Escherichia coli extraintestinal infection. Infect Immun 1999; 67: 546-553.
18. Sifri CD, Begun J, Ausubel FM. The worm has turned -microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol 2005; 13: 119-127.
19. De Champs C, Chanal C, Sirot D et al. Frequency and diversity of class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemother 2004; 54: 634-639.
20. Bonnet R, Dutour C, Sampaio JL et al. Novel cefotaximase (CTX-M-16) with increased catalytic efficiency due to substitution Asp-240→Gly. Antimicrob Agents Chemother 2001; 45: 2269-2275.
21. Dutour C, Bonnet R, Marchandin H et.al. CTX-M-1, CTX-M-3, and CTX-M-14 beta-lactamases from Enterobacteriaceae isolated in France. Antimicrob Agents Chemother 2002; 46: 534-537.
22. Mabilat C, Goussard S, Sougakoff W, Spencer RC, Courvalin P. Direct sequencing of the amplified structural gene and promoter for the extended-broad-spectrum beta-lactamase TEM-9 (RHH-1) of Klebsiella pneumoniae. Plasmid 1990; 23: 27-34.
23. Wang M, Sahm DF, Jacoby GA, Hooper C. Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States. Antimicrob Agents Chemother 2004; 48: 1295-1299.
24. Sirot J. Detection of extended-spectrum plasmid-mediated beta-lactamases by disk diffusion. Clin Microbiol Infect 1996; 2: S35-S39.
25. Gouby A, Neuwirth C, Bourg G et.al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994; 32: 301-305.
26. Clermont O, Bonacorsi S, Bingen E. Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 2000; 66: 4555-4558.
27. Johnson JR. papG alleles among Escherichia coli strains causing urosepsis: Associations with other bacterial characteristics and host compromise. Infect Immun 1998; 66: 4568-4571.
28. Czeczulin JR, Whittam TS, Henderson IR, Navarro-Garcia F, Nataro JP. Phylogenetic analysis of enteroaggregative and diffusely adherent Escherichia coli. Infect Immun 1999; 67: 2692-2699.
29. Johnson JR, Russo TA, Tarr PI et al. Molecular epidemiological and phylogenetic associations of two novel putative virulence genes, iha and iroN (E. coli), among Escherichia coli isolates from patients with urosepsis. Infect Immun 2000; 68: 3040-3047.
30. Johnson JR, Delavari P, Kuskowski M, Stell AL. Phylogenetic distribution of extraintestinal virulence-associated traits in Escherichia coli. J Infect Dis 2001; 183: 78-88.
31. Kurz CL, Chauvet S, Andres E et al. Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J 2003; 22: 1451-1460.
32. Winokur PL, Canton R, Casellas JM, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001; 32: S94-S103.
33. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005; 56: 52-59.
34. Baraniak A, Fiett A, Sulikowska J, Nordmann P, Gniadkowski M. Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob Agents Chemother 2002; 46: 151-159.
35. Eckert C, Gautier V, Saladin-Allard M et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob Agents Chemother 2004; 48: 1249-1255.
36. Lavigne JP, Bouziges N, Chanal C, Mahamat A, Michaux-Charachon S, Sotto A. Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum β-lactamases in a French hospital. J Clin Microbiol 2004; 40: 3805-3808.
37. Yan JJ, Ko WC, Tsai SH, Wu HM, Jin YT, Wu JJ. Dissemination of CTX-M-3 and CMY-2 beta-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J Clin Microbiol 2000; 38: 4320-4325.
38. Boyd DA, Tyler S, Christianson S et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob Agents Chemother 2004; 48: 3758-3764.
39. Brigante G, Luzzaro F, Perilli M et al. Evolution of CTX-M-type β-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int J Antimicrob Agents 2005; 25: 157-162.
40. Conceicao T, Brizio A, Duarte A, Lito LM, Cristino JM, Salgado MJ. First description of CTX-M-15-producing Klebsiella pneumonia in Portugal. Antimicrob Agents Chemother 2005; 49: 477-478.
41. Gangoue-Pieboji J, Miriagou V, Vourli S, Tzelepi E, Ngassam P, Tzouvelekis LS. Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a bla CTX-M-15 -carrying element. Antimicrob Agents Chemother 2005; 49: 441-443.
42. Kim J, Lim YM, Jeong YS, Seol SY. Occurrence of CTX-M-3, CTX-M-15, CTX-M-14, and CTX-M-9 extended-spectrum β-lactamases in Enterobacteriaceae clinical isolates in Korea. Antimicrob Agents Chemother 2005; 49: 1572-1575.
43. Moubareck C, Doucet-Populaire F, Hamze M, Daoud Z, Weill FX. First extended-spectrum-β-lactamase (CTX-M-15)-producing Salmonella enterica serotype Typhimurium isolate identified in Lebanon. Antimicrob Agents Chemother 2005; 49: 864-865.
44. Johnson JR, Goullet P, Picard B, Moseley SL, Roberts PL, Stamm WE. Association of carboxylesterase B electrophoretic pattern with presence and expression of urovirulence factor determinants and antimicrobial resistance among strains of Escherichia coli that cause urosepsis. Infect Immun 1991; 59: 2311-2315.
45. Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005; 56: 463-469.
46. Anyanful A, Dolan-Livengood JM, Lewis T et al. Paralysis and killing of Caenorhabditis elegans by enteropathogenic Escherichia coli requires the bacterial tryptophanase gene. Mol Microbiol 2005; 57: 988-1007.